Monoclonal antibodies have now been in use in the myeloma clinic since November of 2015. Dr. Gareth Morgan of the University of Arkansas Medical Sciences (UAMS) Myeloma Institute shares how they work and where the field is headed. He mentions the development of bi-specific antibodies, which are new drugs that can link an immune cell with the target on the surface of myeloma cells for greater specificity and impact. Learn more about this new class of drugs in this recent show on Myeloma Crowd Radio.
What Do Monoclonal Antibodies Do in Myeloma? from Patient Power on Vimeo.about the author
Jennifer Ahlstrom
Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of HealthTree Foundation (formerly Myeloma Crowd).
Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.